BDX240920C130000
- 109.87
- 0.000.00%
Becton Dickinson & Co Newsroom
Declining Stock and Decent Financials: Is The Market Wrong About Becton, Dickinson and Company (NYSE:BDX)?
Moderna Was Most Shorted S&P 500 Healthcare Stock in August for Second Consecutive Month
Least Shorted S&P 500 Stocks in August
Express News | BD: New Data Shows Some BD Needle-Free Connectors Showed Decreased Risk for CVC-IBO & (Clabsi)I
Becton Dickinson & Co To Go Ex-Dividend On September 9th, 2024 With 0.95 USD Dividend Per Share
September 5th (Eastern Time) - $Becton Dickinson & Co(BDX.US)$ is trading ex-dividend on September 9th, 2024.Shareholders of record on September 9th, 2024 will receive 0.95 USD dividend per share on
How to Play the Market Now: The Case for Defensive Value Stocks
50 Stocks to Invest During the Bull Steepening – Part 1
Russell Companies With the Lowest Tax Rates Expected to Generate $1B in 2025 – GS
Edwards Completes Unit Sale to BD, Expands Stock Buyback
Becton, Dickinson and Company (NYSE:BDX) Looks Interesting, And It's About To Pay A Dividend
BD Completes Acquisition of Critical Care From Edwards Lifesciences
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $312
Barclays analyst Matt Miksic maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and maintains the target price at $312.According to TipRanks data, the analyst has a success rate of 61.4%
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
U.S. to Restart Free COVID Test Program as Cases Spike
(BDX) - Analyzing Becton Dickinson's Short Interest
Least Shorted S&P 500 Stocks in July
The 20 Most Popular Mutual Fund Increases During 2Q - Goldman Sachs
Express News | Hhs: Recommend Health Care Providers Prioritize & Conserve BD Bactec Blood Culture Media Bottles per FDA's Recommendations
Express News | Hhs: Aware of Disruptions in the Availability of BD Bactec Blood Culture Media Bottles
Wells Fargo Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $280
Wells Fargo analyst Larry Biegelsen maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and maintains the target price at $280.According to TipRanks data, the analyst has a success rate of 60